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Unrecognized Preanalytical
Problem with the
Spectrophotometric Analysis
of Cerebrospinal Fluid
for Xanthochromia
To the Editor:
The primary diagnostic test for sub-
arachnoid hemorrhage (SAH)1 is a
computed tomography scan, but be-
cause SAH is found in a small per-
centage of patients with negative
computed tomography results, lum-
bar puncture (LP) and spectropho-
tometric analysis of cerebrospinal
fluid (CSF) for xanthochromia are
still needed to make decisions about
angiography (1). Oxyhemoglobin
(O2Hb) is released from erythro-
cytes (RBCs) in the CSF in vivo and
converted to bilirubin in the lepto-
meninges in a time-dependent pro-
cess. Although the trauma of LP fre-
quently produces RBCs in CSF and
RBC lysis leads to the presence of
O2Hb,nobilirubin is formed in such
cases. The presence of bilirubin is
considered the most specific sign of
SAH, and a LP is recommended 12h
after the appearance of symptoms to
test for the presence of bilirubin
(2, 3). O2Hb and bilirubin have ab-
sorbance peaks at 413–415 nm and
450–460 nm, respectively, but be-
cause of the overlap in absorbance
wavelengths with O2Hb, bilirubin is
preferentiallymeasuredat476nm(2–
4).Nevertheless, avoidanceof hemo-
lysis ex vivowill improve the analysis
of bilirubin in CSF and may make
O2Hb a more reliable marker of
bleeding. We conducted experi-
ments to elucidate why RBCs lyse in
CSF.
ACSF pool was prepared from
nonpathologic CSF samples and
stored at 80 °C (approval from
regional ethics committee not re-
quired). After thawing, RBCs that
had been obtained from volunteers
with informed consent were added
to the CSF pool and a physiological
saline solution to final RBC con-
centrations of 20–100 109/L.We
then centrifuged vials with the so-
lutions at 2000g for 5 min immedi-
ately and at hourly intervals up to
4 h after RBC addition and mea-
sured hemolysis by monitoring the
absorbance at 415 nm (Thermo
Spectronic Unicam UV300). Fig. 1
shows the considerable RBC- and
time-dependent hemolysis values
we obtained. In physiological saline,
only slight hemolysis was observed,
even after 4 h (maximum, 0.039 ab-
sorbance units; data not shown). In-
terestingly, the pH of the CSF
1 Nonstandard abbreviations: SAH, subarachnoid
hemorrhage; LP, lumbar puncture, CSF, cerebro-
spinal fluid; O2HB, oxyhemoglobin; RBC, erythro-
cyte (red blood cell).
Fig. 1. Hemolysis of RBCs added
to a pool of CSF during a 4-h
incubation at ambient tempera-
ture.
Hemolysis was measured by moni-
toring the supernatant absorbance
at 415 nm. The 3 upper curves are
results for the original CSF pool
(pH 8.8), and the 3 lower curves are
results obtained after preincubating
the CSF pool in a 5% CO2 atmo-
sphere, producing an approximate
pH of 7.4. RBCs were added to final
concentrations of 20  109/L (F),
50 109/L (f), and 100 109/L (Œ)
in the CSF pool at pH 8.8, and to final
concentrations of 20  109/L (E),
50 109/L (), and 100 109/L (‚)
in the CSF pool at pH 7.4.
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pool was 8.8 (Radiometer ABL725),
andHCO3
andthePCO2wereunde-
tectable. Thus, the pH increase was
likely caused by the evaporation of
CO2 during handling and storage.
After we subsequently incubated the
CSFpool in aCO2 chamber contain-
ing 5%CO2, thepHdecreased to ap-
proximately 7.4, reflecting physio-
logical pH. When we repeated the
experiment described above at this
pH, we found almost no hemolysis
(Fig. 1), even at the highest RBC
concentration.
We then obtained 53 consecu-
tive routine CSF samples from neu-
rosurgical patients suspected of SAH
and analyzed the samples within
1–2 h of collection. The mean (SD)
pH was 8.07 (0.12). Hemolysis is
also considerable in CSF at pH 8.0,
approximately 20%–40% of the he-
molysis observed at pH 8.8 during
the first hour, although the increase
is less at subsequent hours. Thus,
routine samples obtained for spec-
trophotometric analysis most often
have a pH at which preanalytical he-
molysis takes place.
When 1 mL CSF (equilibrated
to pH 7.4) was added to 6- to 10-mL
vials usually used for LP, the pH in-
creasedata rateof0.01pHunits/min
during the first hour (slightly faster
during the first 30 min), which is
equivalent toan increase in thepHto
7.8–8.0after1h.Agitationof thevial
speeds up this process. The pH
changes were much less in a 2-mL
vial containing 1 mL CSF, and the
physiological pH is conserved if the
vial is completely filled.
The results show that the
amount of hemolysis depends at
least partly on the pH of the CSF
sample and that the pH of CSF in-
creases ex vivo upon exposure to
atmospheric air owing to the evapo-
ration of CO2. If the volume of air
above theCSF in the vial is small and
the vial is capped quickly, changes in
pH are reduced substantially, with
almost negligible hemolysis ex vivo.
Surprisingly, no publications have
described this preanalytical problem,
although several have shown that the
presence of RBCs after a traumatic
tap may cause a falsely increased
O2Hb in the CSF sample (3, 5).
Evaporation of CO2 is well
known to lead to a pH increase in
fluids containing HCO3
. The non-
bicarbonate buffering capacity in
CSF is lowbecauseof the lowprotein
concentration, and the pH increases
quickly if the sample is exposed to
air.Theuseof a small vial completely
filled with CSF and capping the vial
immediately after the LP will mini-
mize the problem and improve the
analysis, because the presence of
O2Hbmay affect the ability to accu-
rately detect bilirubin. This simple
step may even improve the reliabil-
ity of detecting O2Hb as a marker of
SAH sooner than the prescribed 12 h,
but the impact of this approach needs
to be shown in a clinical setting.
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Diagnosis of Metachromatic
Leukodystrophy by Immune
Quantification of
Arylsulphatase A Protein and
Activity in Dried Blood Spots
To the Editor:
Metachromatic leukodystrophy
(MLD),1 an autosomal recessive
neurodegenerative disease result-
ing from a deficiency of arylsulfa-
tase A (ASA), results in the lysoso-
mal accumulation of sulfatide in
several peripheral organs, notably
the central nervous system. The
1 Nonstandard abbreviations: MLD, metachromatic
leukodystrophy; ASA, arylsulfatase A; ASA-PD,
ASA pseudo-deficiency; DBS, dried blood spots.
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